| Literature DB >> 35729629 |
Antero Vanhala1, Anna-Rosa Lehto2, Anu Maksimow3, Paulus Torkki4, Sanna-Maria Kivivuori3.
Abstract
BACKGROUND: The choice of what patient outcomes are included in clinical quality registries is crucial for comparable and relevant data collection. Ideally, a uniform outcome framework could be used to classify the outcomes included in registries, steer the development of outcome measurement, and ultimately enable better patient care through benchmarking and registry research. The aim of this study was to compare clinical quality registry outcomes against the COMET taxonomy to assess its suitability in the registry context.Entities:
Keywords: COMET; Comparative effectiveness research; Outcome assessment; Outcome measures; Patient registry; Real-world data
Mesh:
Year: 2022 PMID: 35729629 PMCID: PMC9215071 DOI: 10.1186/s12913-022-08132-w
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
List of investigated clinical quality registries and occurrence of COMET taxonomy core areas
| Clinical quality registry | COMET core areas found | Clinical quality registry | COMET core areas found | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Death | Physiological/clinical | Life impact | Resource use | Adverse events | Death | Physiological/clinical | Life impact | Resource use | Adverse events | ||
| Asthma | ○ | ● | ● | ● | ● | Multiple sclerosis | ○ | ● | ● | ● | ● |
| Back surgery | ○ | ● | ● | ● | ● | Nasal airway surgery | ○ | ● | ● | ● | ● |
| Bariatric surgery | ○ | ● | ● | ● | ● | Nephrology (N) | ● | ● | ● | ● | ● |
| Brain tumors (N) | ● | ● | ● | ● | ● | Neuromodulator | ○ | ● | ● | ● | ● |
| Breast cancer - Oncology | ● | ● | ⋄ | ● | ● | Pacemaker | ● | ● | – | ● | ● |
| Breast cancer - Surgery (N) | ● | ● | ● | ● | ● | Pain | ○ | ● | ⋄ | ● | ● |
| Cataract | ○ | ● | ● | ● | ● | Pediatric and adolescents’ cancer | ○ | ● | ● | ● | ● |
| Cerebral stroke (N) | ○ | ● | ● | ● | ● | Pediatric back surgery | ○ | ● | ● | ● | ● |
| Cleft Palate and Craniofacial | ○ | ● | ● | ● | ● | Pediatric cancer | ● | ● | ● | ● | ● |
| Colon and rectal cancer - Oncology | ● | ● | ⋄ | ● | ● | Pediatric fractures | ○ | ● | ● | ● | ● |
| Colon and rectal cancer - Surgery | ● | ● | ● | ● | ● | Pediatric heart surgery | ● | ● | ● | ● | ● |
| COVID19 | ● | ● | ● | ● | – | Prostate cancer - Oncology | ● | ● | ⋄ | ● | ● |
| Diabetes (N) | ○ | ● | ● | ● | ● | Prostate cancer - Surgery | ○ | ● | ● | ● | ● |
| Epilepsy | ○ | ● | ● | ● | ● | Rare diseases (N) | ● | – | ⋄ | ● | – |
| Fractures | ○ | ● | ● | ● | – | Renal cancer - Oncology | ● | ● | ⋄ | ● | ● |
| Gynecologic cancer (N) | ● | ● | ● | ● | ● | Renal cancer - Surgery (N) | ○ | ● | ⋄ | ● | ● |
| Head and neck cancer - Oncology | ● | ● | ⋄ | ● | ● | Retina | ○ | ● | ⋄ | ● | ● |
| Head and neck cancer - Surgery (N) | ● | ● | ● | ● | ● | Rheumatism | ● | ● | ● | ● | ● |
| Heart and lung transplant | ● | ● | ● | ● | ● | Sarcoma and GIST | ● | ● | ⋄ | ● | – |
| Heart surgery | ● | ● | – | ● | ● | Skin cancer - Oncology (N) | ● | ● | ⋄ | ● | ● |
| Hepatitis C (N) | ○ | ● | ⋄ | ● | – | Skin cancer - Surgery (N) | ● | ● | – | ● | ● |
| Hernias | ○ | ● | ● | ● | ● | Spinal injury | ○ | ● | ● | ● | ● |
| Hip surgery (N) | ○ | ● | ● | ● | ● | Tissue flap surgery (N) | ● | ● | – | ● | ● |
| Inflammatory bowel disease | ○ | ● | ● | ● | ● | Transcatheter valve replacement | ● | ● | ● | ● | ● |
| Intensive care | ● | ● | ● | ● | ● | Trauma and injury (N) | ● | ● | ⋄ | ● | – |
| Invasive cardiology | ● | ● | ⋄ | ● | ● | Upper gastroenterological cancer | ● | ● | ⋄ | ● | ● |
| Kidney and pancreas transplant | ● | ● | ● | ● | ● | Urogynecology (N) | ○ | ● | ● | ● | ● |
| Knee surgery (N) | ○ | ● | ● | ● | ● | Urothelial cancer (N) | ● | ● | ● | ● | ● |
| Liver transplant | ● | ● | ● | ● | ● | Vascular anomalies | ○ | ● | ● | ● | ● |
| Lung cancer (N) | ● | ● | ● | ● | ● | Vascular surgery | ● | ● | ⋄ | ● | ● |
| Lymphoma - Oncology | ● | ● | ⋄ | ● | ● | Venous surgery (N) | ○ | ● | – | ● | – |
| Medical Emergency Team, Resuscitation | ● | ● | ⋄ | ● | – | ||||||
Explanations: ● Core area was explicitly found in the registry, − Core area was not found in the registry, ○ Death outcome was not explicitly tracked, but status can be accessed any time, ⋄ No other life impact domain was found except for Domain 32 Delivery of care that includes, for example, waiting times. (N) The registry contained nationally tracked measures
Frequency of measures in each COMET outcome domain in investigated registries
| Core area | Outcome domain | At least once, nr of registries (%) | Median number of outcome measures per registry (range) |
|---|---|---|---|
| Death | 1. Mortality/survival | 35 (56) | 6 (1 to 49) |
| Physiological/clinical | |||
| 2. Blood and lymphatic system outcomes | 18 (29) | 1 (1 to 5) | |
| 3. Cardiac outcomes | 28 (44) | 2.5 (1 to 151) | |
| 4. Congenital, familial, and genetic outcomes | 4 (6) | 1 (1 to 1) | |
| 5. Endocrine outcomes | 8 (13) | 2 (1 to 7) | |
| 6. Ear and labyrinth outcomes | 8 (13) | 1 (1 to 6) | |
| 7. Eye outcomes | 14 (22) | 2 (1 to 87) | |
| 8. Gastrointestinal outcomes | 27 (43) | 3 (1 to 54) | |
| 9. General outcomes | 48 (76) | 5 (1 to 46) | |
| 10. Hepatobiliary outcomes | 13 (21) | 2 (1 to 46) | |
| 11. Immune system outcomes | 19 (30) | 2 (1 to 28) | |
| 12. Infection and infestation outcomes | 30 (48) | 2 (1 to 23) | |
| 13. Injury and poisoning outcomes | 9 (14) | 1 (1 to 6) | |
| 14. Metabolism and nutrition outcomes | 12 (19) | 1 (1 to 40) | |
| 15. Musculoskeletal and connective tissue outcomes | 25 (40) | 3 (1 to 134) | |
| 16. Outcomes relating to neoplasms: benign, malignant, and unspecified | 25 (40) | 13 (1 to 34) | |
| 17. Nervous system outcomes | 33 (52) | 2 (1 to 126) | |
| 18. Pregnancy, puerperium, and perinatal outcomes | 7 (11) | 1 (1 to 2) | |
| 19. Renal and urinary outcomes | 25 (40) | 4 (1 to 64) | |
| 20. Reproductive system and breast outcomes | 11 (17) | 4 (1 to 31) | |
| 21. Psychiatric outcomes | 10 (16) | 4.5 (1 to 29) | |
| 22. Respiratory, thoracic, and mediastinal outcomes | 25 (40) | 3 (1 to 234) | |
| 23. Skin and subcutaneous tissue outcomes | 30 (48) | 1,5 (1 to 45) | |
| 24. Vascular outcomes | 39 (62) | 5 (1 to 34) | |
| Life impact | |||
| 25. Physical functioning | 37 (59) | 11 (1 to 239) | |
| 26. Social functioning | 23 (37) | 3 (1 to 36) | |
| 27. Role functioning | 31 (49) | 3 (1 to 16) | |
| 28. Emotional functioning/well-being | 22 (35) | 7 (1 to 70) | |
| 29. Cognitive functioning | 22 (35) | 3 (1 to 30) | |
| 30. Global quality of life | 3 (5) | 1 (1 to 2) | |
| 31. Perceived health status | 22 (35) | 4 (1 to 32) | |
| 32. Delivery of care | 53 (84) | 4 (1 to 58) | |
| 33. Personal circumstances | 18 (29) | 1 (1 to 28) | |
| Resource use | |||
| 34. Economic | 27 (43) | 4 (1 to 73) | |
| 35. Hospital | 48 (76) | 3.5 (1 to 14) | |
| 36. Need for further intervention | 63 (100) | 35 (4 to 225) | |
| 37. Societal/carer burden | 9 (14) | 2 (1 to 49) | |
| Adverse events | 38. Adverse events/effects | 55 (87) | 6 (1 to 30) |
Number (and %) of registries containing at least one outcome measure pertaining to each COMET taxonomy outcome domain [27], and median (and range) number of outcome measure items in the registries containing that domain. Total number of registries was 63. Please note, as instructed by COMET authors, Domain 30. Global quality of life is reserved for unidimensional health-related quality of life questions, and composite scores for quality of life should be recorded for all domains that are included in the full questionnaire tool sub-questions; Domain 38. Adverse events/effect: Specified adverse effects of care are classified into their relevant physiological domains and marked with an additional sub-class, “Harm”; and Domain 38. Adverse events/effects is reserved for unspecified adverse events or effects (e.g., “Other adverse effect”)